Eliot Listman was named Allia Group Chief Executive Officer in February 2021. He oversees the firm’s strategic direction, sourcing of investments, financial structuring, and the management of litigation across its platform.
Since joining Allia Group, he has become a committed advocate for equitable economics for healthcare providers and has pioneered an innovative healthcare litigation finance model. This litigation strategy creates balance by addressing insurer practices that result in underpayment to healthcare providers.
Eliot has the privilege of collaborating with an exceptionally talented team. The team’s diverse expertise spans litigation finance, medicine, healthcare policy, and revenue cycle management.
Before becoming CEO, he served in senior positions at multiple public and private companies. Earlier in his career, Eliot practiced law at both Wall Street and international law firms.
Eliot holds a JD from The National Law Center of the George Washington University, a Master’s in Government Administration from the University of Pennsylvania’s Fels Center of Government, a General Course degree from The London School of Economics, and a BA from Vassar College.
For years, out-of-network reimbursement worked on payer terms. Rates were set, payments were issued, and providers had limited recourse.
Healthcare reimbursement is often described as a system of rules, contracts, and good-faith exchange. A provider delivers care, documents it, submits a claim, and receives payment. Simple enough.
A recent study commissioned by the Americans for Fair Health Care (AFHC), evaluating the Qualifying Payment Amounts (QPAs) under the No Surprises Act (NSA) Independent Dispute Resolution (IDR) process, finds that reported QPAs do not align with the actual median in-network contracted rates.